Introdiiction
Compaction at the cytoplasmic apposition of multilammellar myelin sheaths in the central nervous system (CNS) is facilitated by an extrinsic membrane polypeptide, myelin basic protein (MBP). MBP has long been a focus of attention in studies on multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). MBP levels are reduced in white matter from MS and EAE tissue, and MBP fragments in spinal fluid samples may be diagnostic for ongoing demyelination (Whitaker, 1984) . In addition, MBP is a potent inducer of EAE in many species (Kies, 1985) .
Extracellular disintegration of myelin sheaths has been observed by electron microscopy of EAE CNS tissue. At the edge of dissolving compact myelin, each lamella often has a small membranous loop, arising from a split at the cytoplasmic apposition (Lampert, 1983) . This observation raises the possibility that proteinases acting within the myelin sheath itself could degrade MBP and contribute to this pattern of myelinolysis.
Myelin membranes can be isolated, with little contamination from other neural organelles, by density gradient centrifugation. MBP is labile when myelin membranes are incubated at physiological ionic strength because of neutral protease activities in the preparations (Sato et a/., 1982) . Recently we have examined MBP interactions with isolated myelin membranes in some detail (Glynn et ul., 1987; Earl et al., 1988) . The critical first step in the degradation of MBP in this system is its dissociation Ahhrcviationh used: CNS, central nervous system: MBP, myelin basic protein; MS, multiple sclerosis; EAE, experimental autoimmune encephalomyelitis; SDS/PAGE, SDS/polyacrylamide-gel clectrophoresis; DTT, dithiothreitol; 1. I 0-PA, I , 1 0-phenanthroline; PMSF, phenylmeihylsulphonyl fluoride: Chaps, 3-(3-cholamidopropyldimethy1amonio)-I -propane sulphonate.
from the membrane surface. Zinc ions protect MBP from proteolysis by stabilizing its binding to the membrane, while calcium ions promote dissocation. In the presence of Ca2 +, a steady state is attained within a few hours, where about 65% of the original MBP is lost from the membranes. Approximately 15% of the MBP is detected in incubation media as a mixture of the intact protein (18.4 kDa) and polypeptides ( > 8 kDa), while 50% of the MBP is degraded to fragments too small to bind Coomassie Blue (Fig. 1 ) .
Humoral and cellular components of inflammatory infiltrates in CNS tissue of MS and E A E could permeabilize the lipid bilayers of myelin sheaths. This would allow extracelMar fluid into the cytoplasmic space which could trigger dissociation of MBP from the membrane surface and its subsequent degradation by the myelin-associated proteinases. To determine whether these events actually occur in vivo, we aim to use immunohistochemistry on MS and EAE CNS tissue to localize the putative myelin-associated proteinase and the major fragments of MBP generated by its activity. The present report describes our progress in characterizing these MBP polypeptides and the proteinase.
Characterization of MBP fragments
MBP fragments in myelin incubation media were separated by SDS/polyacrylamide-gel electrophoresis (PAGE) (cf. Fig. 1 ) and immunoblotted against three different antibodies to defined epitopes of MBP. Two major polypeptides, designated C ( 10.3 kDa) and D (8.4 kDa), were thus confirmed as the C-and N-terminal fragments, respectively, probably arising from a single cleavage of MBP 1 -170 near residue 75 (Glynn etal., 1987; .
Peptide C was isolated from myelin membrane incubation media by gel filtration on Sephadex G-50 and affinity chromatography. Initially, it was found to be refractory to Nterminal analysis. However, after treating the peptide with pyroglutamate aminopeptidase, N-terminal sequencing could proceed. The sequence obtained indicated that proteolysis had exposed Gln-74 of MBP as the new N-terminal and that this Gln had then cyclized to a pyroglutamyl moiety. To test the possibility that this new N-terminal would represent
Fig. 1. Interaction of MHP with myelin membranes arid its siisceptihility to proteolysis
Myclin membranes ( 5 mg of protein/ml) were incubated (37°C) in 160 mM-Tris/HCI, pH 7.4 containing 2 mM-MgCI, and 2 mM-CaC12. After 4 h (steady state), incubation mixtures were centrifuged to separate membranes from media. Proteins were separated by SDS/PAGE stained with Coomassie Blue and quantified by densitometry (Glynn et ul., 1987 (Groome et al., 1988) . Anti-P28 serum showed no immunoreactivity on cryostat sections of human brain tissue from two MS cases and an individual without neurological disease (data not shown). However, in some white matter sections from a particularly active case of MS, irregular structures were stained with immunoperoxidase substrate after incubation with anti-P28 (Fig. 2 6 ) . Some of these structures were apparently associated with cell nuclei, while others were not (Fig. 2c) . Anti-P7 serum which reacts with intact MBP produced a uniform immunoperoxidase stain on these sections, suggesting that demyelination had not proceeded beyond an early stage (Fig. 2a) .
Characterization of neutral proteinase
Although the detection of immunoreactive peptide C on MS brain tissue sections provides preliminary evidence for its production in vivo, it does not necessarily imply the involvement of a myelin-specific proteinase. Degradation of MBP in isolated myelin membranes could result from proteinases of non-myelin/oligodendrocyte origin contaminating the preparation. Because of the association of myelin with axons in vivo, contamination from axonal or synaptosomal elements may be particularly significant. Axons are a source of leupeptin-sensitive calcium-activated neutral proteinases (Nilsson & Karlson, 1986) and synaptosomal membranes contain the phosphoramidon-sensitive neutral metalloproteinase, endopeptidase 24.1 1 (Matsas et al., 1985) . However, in isolated myelin membranes, formation of peptide C was not affected by leupeptin or phosphoramidon. In addition, no effect was seen with inhibitors of serine proteinases In the preceding experiments, metalloendoproteinase activity in myelin membranes was detected by proteolysis of endogenous MBP, which comprises about 30% of the total protein in these preparations. The formation of peptide C in incubation media could be determined simply by densitometry of Coomassie-Blue-stained gels since no other major proteins co-migrated in this system. To detect a peptide-Cgenerating proteinase activity in crude soluble or particulate fractions from neural and other tissues, a more selective assay was required. After incubating crude samples with purified human MBP, peptide C could be determined unequivocally by immunoblotting against anti-P28 serum (cf. Fig. 3) . Using this methodology, human MBP was converted to peptide C by particulate, but not soluble fractions, from homogenates of rat brain and sciatic nerve. The same technique revealed the presence of peptide-C-generating activity in myelin preparations from the brains of chicken, lizard, frog, and fish. In addition, preliminary ontogenic studies found activity in rat brain particulate fractions as early as post-natal day 1, several days before endogenous immunoreactive MBP was detected. Exogenous MBP was also converted to peptide C by the particulate fraction of the mouse macrophage-like cell line, P388. By contrast, liver and heart appeared to be devoid of this activity. In spleen and kidney, however, high overall proteolytic activities consumed the substrate, MBP, so rapidly that any conversion to peptide C could not be evaluated with confidence (data not shown).
The conversion of MBP to peptide C by activities in various tissues indicates only the presence of proteinases capable of cleaving a specific bond in M B P it does not prove the presence of an identical enzyme in myelin and other tissues. For example, a-proteinase in Croatalus atrox venom appears to cleave preferentially the Pro-73-Gln-74 bond in MBP peptide 45-89 (Nomura et al., 1977) .
More precise characterization and localization of the proteinase requires its isolation from myelin membranes. The activity appeared to be firmly associated with these membrane preparations and was not extracted by washing with 
Fig. 3. Gel Jiltrutiori of Chaps-solitbilized proteiris from MBP-depleted rat myeliri m e m brunes
Myelin membranes ( 3 mg of protein/ml), depleted of MBP as noted in the text, were extracted ( 1 h; 4°C) with 1% (v/v) Chaps in 50 m~-Tris/HCl, pH 7.4 containing 0.1 MNaCI, 2 mM-CaClz, 2 m~-MgCl,, 1 mM-PMSF, 0.02 mM-leupeptin and then centrifuged (40 000 g for 1 h). Extracted proteins (4.8 mg) were applied to a column ( 1.6 cm x 90 cm) of Sephacryl-S300 run in the same buffer with 0.6% Chaps at 10 ml/h (4°C). The polypeptide profile was established by SDS/PAGE and the column calibrated using proteins of known Mr; Blue Dextran (BD), 2000 kDa; apoferritin (ApoF), 443 kDa; IgG, 150 kDa; albumin (Alb.), 67 kDa; ovalbumin (Ovalb.), 43 kDa. Formation of peptide C was assayed by incubating (37°C for 1 h) fractions (diluted 2-fold) with purified human MBP (1 mglml). Reaction mixtures were immunoblotted against anti-P28 serum. Purified peptide C (3,0.5,0.3 pg) served as a semiquantitative standard. Fractions positive for specific protease activity are indicated, V.
high or low ionic strength media (data not shown). To allow comparison of the rates of conversion of exogenous MBP to peptide C at various stages of proteinase isolation, the membranes were initially depleted of at least 80% of their endogenous MBP by two incubations under the conditions described in Fig. 1 . Thereafter, metalloproteinase activity representing approximately 50-80% of that originally associated with myelin membranes could be solubilized from myelin membranes using the non-ionic detergent 3-( 3-cholamidopropyldimethylamonio) -1 -propane sulphonate (Chaps). Separation of this extract by gel filtration on Sephacryl S-300 revealed a discrete peak of activity capable of converting MBP to peptide C. Molecular mass determinations based on the migration of standard proteins under identical conditions yielded an estimate of 300-360 kDa (Fig. 3) .
Discirssiori
MBP is cleaved, probably at the Pro-73-Gln-74 bond, by a metalloendoproteinase, putatively associated with myelin membranes. The same enzyme may also mediate more extensive proteolysis of MBP, forming oligopeptides incapVol. 16 able of binding Coomassie Blue. An antiserum against the major C-terminal MBP fragment of the limited cleavage reacts with structures in the white matter of active MS cases. This provides preliminary evidence that metalloendoproteinase degradation of MBP could contribute to the early stages of demyelination in MS. Clearly, many sections must now be similarly analysed, by both light and electron immunomicroscopy, to confirm these observations and to localize the staining to specific cells and their processes.
Initial characterization of the metalloproteinase activity in myelin preparations by inhibitor sensitivities distinguish it from the major group of calcium-activated proteinases and from endopeptidase 24.1 1. Recently, a synaptosomal membrane form of endopeptidase 24.1 5 has been reported (Acker et ul., 1987) . This activity preferentially cleaves bonds between hydrophobic amino acids in peptides and is inhibited by 1,10-PA. Thus, endopeptidase 24.15 activity might be responsible for the conversion of MBP to peptide C in myelin membranes. The activity in myelin also shares insensitivity to phosphoramidon with a mouse kidney membrane-bound metalloendoproteinase, meprin. Toluene/ trypsin-solubilized preparations of meprin migrate on gel filtration with an apparent M , around 270-320 kDa (Beynon et al., 1981) , a value similar to that for the proteinase solubilized from myelin membranes. When the metalloproteinase activity from myelin membranes is purified to homogeneity it can be compared more accurately with meprin and endopeptidase 24.1 5. In addition, antibodies against this proteinase should permit immunoelectron microscopy to pinpoint its subcellular localization in the nervous system.
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